На главнуюНаука и техникаПохожее видеоЕще от: RxWikiTV

Pulmonary Arterial Hypertension Rx Combo Approved

Оценок: 4 | Просмотров: 824
http://www.rxwiki.com/news-article/letairis-ambrisentan-combination-tadalafil-adcirca-approved-treat-pulmonary-arterial Together, two medications for pulmonary arterial hypertension (PAH) may help patients even more than either pill alone. That's why the US Food and Drug Administration (FDA) recently approved ambrisentan (brand name Letairis) in combination with tadalafil (Adcirca) to treat PAH. The combination of these drugs appeared to slow the progression of PAH and reduce the risk of hospitalization. The FDA approved Letairis in 2007 to treat PAH. Tadalafil was approved in 2009 to treat PAH. “The evidence to support the use of ambrisentan and tadalafil in PAH is well-established, however an outstanding question has been whether combining these two medications up front may further delay the progression of this disease over the long term for patients who are newly starting PAH therapy,” said Ronald J. Oudiz, MD, director of the Liu Center for Pulmonary Hypertension at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, in a press release.
Категория: Наука и техника
Html code for embedding videos on your blog
Текстовые комментарии (0)

Хотите оставить комментарий?

Присоединитесь к YouTube, или войдите, если вы уже зарегистрированы.